Decoding Your NIH Summary Statement: What Each Score and Comment Actually Means
Your summary statement is the single most important document you will read in the entire grant cycle. It is also written in a language that is learned, not intuitive. Reviewer phrases that sound negative are often neutral, phrases that sound glowing can hide concerns, and the arrangement of praise versus weakness carries more weight than most applicants notice on the first read. This guide walks through what to actually look at.
Table of Contents
- What a Summary Statement Actually Contains
- The Resume of Discussion: The Section That Matters Most
- Translating Reviewer Language: What "Enthusiastic" Actually Means
- Score Spread vs Score Drift: Reading Individual Criterion Scores
- Impact Score vs Percentile: Why the Gap Matters
- When the Statement Points to a Real A1 Path
- When the Statement Is Telling You Not to Resubmit
- A Reading Workflow for the First 48 Hours
- Frequently Asked Questions
What a Summary Statement Actually Contains
A discussed R01 summary statement has six major pieces: the administrative header, the Resume and Summary of Discussion written by the Scientific Review Officer, the three (sometimes four) individual reviewer critiques, the criterion scores, the Overall Impact score, and the percentile. A triaged application receives only the individual critiques and criterion scores — no resume, no impact score, no percentile. If you see a resume at the top, you were discussed at the meeting. If you do not, you were not.
Each section tells you something different. The individual critiques tell you what each reviewer thought before the meeting, in their own voice. The Resume of Discussion tells you what the panel actually agreed on after discussion — which is where views consolidate and where you learn the real verdict. The scores tell you how much the disagreements mattered numerically. The percentile tells you where you landed relative to the study section's overall distribution, which is what drives funding decisions.
Most applicants open the individual critiques first and get stuck there. That is a mistake. The Resume of Discussion is what you should read first, and carefully, because it is the only section that represents consensus rather than a single reviewer's take.
The Resume of Discussion: The Section That Matters Most
The Resume of Discussion is written by the Scientific Review Officer (SRO) and captures the panel's consensus after discussion. It is typically a few paragraphs long and it is the closest thing you get to a transcript of what happened when your application was discussed. Read it two or three times before you read anything else.
Pay attention to three things as you read it. First, the balance — is the praise concentrated at the start and the concerns at the end, or the reverse? A resume that opens with concerns and closes with caveats signals a panel that was unconvinced despite some strong points. A resume that opens with praise and closes with one or two specific concerns signals a panel that was generally positive but had actionable issues.
Second, the specificity of the concerns. A resume that lists concrete technical concerns ("the proposed sample size of 30 may be insufficient for the interaction analysis in Aim 2") points toward a real A1 path because you can address those concerns directly. A resume that raises broad conceptual concerns ("the panel was not convinced that the central hypothesis is sufficiently novel to justify R01 investment") is a harder signal, because reframing novelty is a much bigger lift than tightening a sample size.
Third, any phrase about investigator experience or preliminary data. Concerns about investigator qualifications or insufficient preliminary data are among the most persistent reviewer worries and the hardest to fully resolve in an A1, especially for new investigators. If the resume raises either of these issues explicitly, budget more revision time than you might expect.
Translating Reviewer Language: What "Enthusiastic" Actually Means
Reviewer prose uses a narrow set of phrases that map to a narrow set of scores, and learning this vocabulary is one of the most practically useful things you can do between submissions.
Positive language calibration
- "Exceptional" or "outstanding" — points toward a score of 1 or 2. These words are used sparingly and should be taken at face value.
- "Strong" or "highly significant" — points toward a score of 2 or 3. Positive, but one notch below exceptional.
- "Enthusiastic" or "high enthusiasm" — usually signals a score of 2 or 3. Watch for whether the enthusiasm is qualified elsewhere.
- "Solid" or "well-designed" — typically a 3 or 4. Competent, but not outstanding.
- "Generally appropriate" or "reasonable" — typically a 4 or 5. This is the most widely underread phrase in summary statements. It is not praise; it is damning with faint language.
Negative language calibration
- "Concerns were raised" — neutral in the aggregate, but specific concerns in a 1-to-1 reviewer critique usually cost you a point unless countered by others.
- "Ambitious" — almost always a negative. In NIH review language, "ambitious" is code for "the panel does not believe this is feasible as proposed."
- "Descriptive" — a well-known red flag for low Innovation. The panel is saying the work catalogs observations without generating mechanistic insight.
- "Fishing expedition" — a serious concern about hypothesis-driven design. Usually requires a reframing of the approach, not just a tightening.
- "The rationale is not clear" — this is a structural problem with the Specific Aims or the significance, not a detail. It usually requires substantial rewriting.
Score Spread vs Score Drift: Reading Individual Criterion Scores
Each assigned reviewer gives five criterion scores (Significance, Investigator(s), Innovation, Approach, Environment) and an Overall Impact score, all on a 1 to 9 scale. You will see the individual reviewer scores for each criterion listed in the summary statement. Reading these scores as a group tells you more than reading them one at a time.
Score spread is when your three reviewers give substantially different scores on the same criterion — for example, one reviewer gives you a 2 on Approach while the others give you 4 and 5. Spread signals that reviewers disagreed about something specific. In many cases, this is a sign that the panel discussion would have been decisive — either the optimistic reviewer talked the others up, or the pessimists talked the optimist down. Your final Overall Impact score tells you which way the conversation went.
Score drift is when the reviewers give similar scores across all five criteria — for example, all three reviewers give you 3-3-4-3-3 on the five criteria. Drift signals that the panel broadly agreed, which is useful to know because it means the central problems with the application are shared and identifiable. An A1 that addresses those shared concerns has a real path forward.
Tight clustering at high scores (say, all three reviewers at 2 or better across the board) with a middling Impact score is a specific pattern worth noting. It usually means the panel as a whole was less impressed than the assigned reviewers were, and your pre-meeting score came down at discussion. This is the hardest pattern to respond to, because the individual critiques do not fully explain what the panel cared about.
Impact Score vs Percentile: Why the Gap Matters
Your Overall Impact score is a 10 to 90 number (the average of all panel-member scores multiplied by 10). Your percentile is the ranking of that score against the study section's distribution over recent cycles. These two numbers can tell very different stories.
A 30 Impact score with a 25th percentile means your study section is highly competitive — your score is fundable in absolute terms but still in the middle of the pack. A 30 Impact score with an 8th percentile means your study section runs harder on scoring — the same number puts you in striking distance of funding. Institute pay lines are usually expressed in percentiles, so the percentile is what ultimately matters for your award decision.
If your Impact score is good but your percentile is not, the problem is not your application — it is your study section. An A1 to the same study section may not change your fate. Consider, in consultation with your Program Officer, whether a study section change is worth requesting in the cover letter of the resubmission.
When the Statement Points to a Real A1 Path
Some summary statements tell you exactly how to improve the application. Learning to recognize this pattern saves weeks of strategy debate.
The clearest positive signal is a score in the high teens to low twenties with specific, concrete, mechanical concerns in the resume. A 19 Impact score with concerns about sample size, authentication of a specific reagent, and clarity of a single statistical model is the textbook case for an A1 that moves you into the funded zone. Every concern is fixable, none require reconceiving the project, and the panel has already signaled that the core science is strong.
A second positive signal is a clear score spread with a single strong advocate. When one reviewer gives you excellent scores and the other two are lukewarm, your A1 should be written primarily to convince the two lukewarm reviewers. Address their specific concerns directly in the Introduction to the Resubmission and make the changes visible in the body of the Research Strategy. Panel dynamics often favor the advocate when the objectors' concerns have been addressed concretely.
A third pattern that signals a real A1 is explicit language in the resume about what would make the application stronger. The phrase "the reviewers agreed that with additional preliminary data on X, the proposal would be substantially more competitive" is a roadmap. Take it seriously, and structure your revision around it.
When the Statement Is Telling You Not to Resubmit
Not every summary statement points to a resubmission. Some point to a reframe, a mechanism change, or a different funding target entirely. The patterns that suggest stepping back are worth taking seriously, even when they are uncomfortable.
The panel did not believe the central premise
If the resume questions whether your central hypothesis is correct or whether your framing of the problem is right, an A1 will not usually fix it. Reviewers who did not believe the premise on A0 rarely change their mind on the same core project. Consider reframing the work and submitting as a new application rather than as an A1.
Investigator concerns dominate the resume
When the panel raises substantial concerns about your qualifications or the team's capacity to deliver, the A1 has to do more than improve the science — it has to convince the panel that you can execute. If you are a new investigator, this may mean adding senior consultants, publishing preliminary results in a peer-reviewed venue before resubmission, or waiting a cycle to build the record.
The score is out of A1 range
Impact scores in the 50s or higher rarely move into fundable territory on A1, even with strong revisions. NIH allows one resubmission, and committing to it for an unfunded score in the 50s or 60s is often a worse use of your time than reworking the project and submitting as A0 to a different mechanism or institute.
A Reading Workflow for the First 48 Hours
The emotional reality of opening a summary statement is that most applicants cannot read it clearly the first time through. Here is a workflow that separates emotional response from strategic analysis.
Day one. Open it, read the Impact score and percentile, close the document, and put it away for 24 hours. Do not reply to reviewer comments mentally during this time. Do not draft a response. Sit with the numbers.
Day two, first pass. Read only the Resume of Discussion, twice. Write down, in your own words, three things the panel liked and three things the panel was concerned about. Do not read individual reviewer critiques yet.
Day two, second pass. Read the individual critiques, one at a time. Note which reviewer concerns appear in the resume (those matter) and which do not (those may be individual views that did not carry the panel).
Day two, end. Write a one-paragraph summary of the panel's overall view, in plain language. If you cannot write this paragraph cleanly, you are not ready to decide on a resubmission yet. Wait another day and try again.
Day three or later. Contact your Program Officer. They have seen the panel discussion from the inside and can tell you how your score compares to other applications in their portfolio. They will not always tell you whether to resubmit, but they will answer pointed questions, and their view often clarifies things the statement leaves ambiguous.
Frequently Asked Questions
Can I appeal a summary statement?
You can request an appeal through your Program Officer if you believe there was a factual error or a conflict of interest in review. Appeals are rare and rarely succeed. The better path for most applicants is a revised resubmission.
Should I call the assigned reviewers?
No. Contacting reviewers during or after review is a conflict of interest and explicitly prohibited. All post-review communication goes through your Program Officer and the SRO.
Is it worth resubmitting a triaged application?
Often yes, but the revision should be substantial. Triaged applications lack a Resume of Discussion, which means your A1 must address the individual critiques without the benefit of knowing which concerns were panel consensus. Budget extra time.
How long do I have to resubmit?
The current NIH policy allows a resubmission at any time after receipt of the summary statement, but practical reality is that a strong A1 takes three to six months to prepare. Do not rush into the next receipt date just because it is available.
Does NIH still allow A2 resubmissions?
No. Since 2014, NIH has allowed only one resubmission per application. After A1, if the application is still unfunded, you must submit as a new application (A0) rather than as an A2. A true new application may reuse portions of the science, but must represent a new proposal.
Before You Commit to a Resubmission
Spending a cycle drafting an A1 to a study section that is running tight on your topic is a strategic decision. The tools below help you confirm that the topic, institute, and mechanism still look favorable before you invest the time.
Related Reading
Explore more resources to enhance your NIH funding knowledge
NIH Study Sections Explained: How Peer Review Really Works
A detailed guide to how panels are organized, how reviewers score, and how percentiles translate into funding decisions.
NIH R01 Grant: The Complete Guide
Eligibility, application components, review process, scoring, and strategies for first-time R01 applicants.
Writing the NIH Specific Aims Page
A structure that survives review, the failures that sink applicants, and a workflow for testing the page.
How to Use Recent NIH Award Data to Time Your Application
A workflow for reading NIH awards and trends to pick a stronger submission cycle without overreacting to noise.
Trust & Transparency
How this content is reviewed before it goes live
NIH Grant Explorer combines public NIH records with editorial interpretation. We publish the review structure, methodology, and correction pathways so readers can judge the value of a guide or chart for themselves.
When a topic turns into an official policy question, we point readers back to NIH rather than pretending an independent site can replace the underlying federal guidance.
Contributors & Review Desks
See how data, strategy, and career-focused pages are reviewed.
Editorial Guidelines
How we source, update, and correct articles and tool explanations.
Data & Methodology
Refresh cadence, public-source coverage, and chart caveats.
Corrections & Contact
Send corrections, feedback, or contributor inquiries.